|
Wolfrum, Sebastian; Grimm, Michael; Heidbreder, Marc et al. (2003) Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol 41:474-80
|
|
Chiarugi, Alberto; Moskowitz, Michael A (2003) Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 85:306-17
|
|
Takemoto, Masao; Sun, Jianxin; Hiroki, Junko et al. (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106:57-62
|
|
Hafezi-Moghadam, Ali; Simoncini, Tommaso; Yang, Zequan et al. (2002) Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:473-9
|
|
Takemoto, M; Node, K; Nakagami, H et al. (2001) Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108:1429-37
|
|
Takemoto, M; Liao, J K (2001) Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21:1712-9
|
|
Amin-Hanjani, S; Stagliano, N E; Yamada, M et al. (2001) Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32:980-6
|
